Integragen S.A. logo

Integragen S.A. (7N8)

Market Closed
17 Jul, 20:00
XSTU XSTU
0. 15
+0
+1.3423%
3.07M Market Cap
- P/E Ratio
- Div Yield
9,667 Volume
- Eps
0.15
Previous Close
Add Transaction
Day Range
0.15 0.15
Year Range
0.07 0.33
Want to track 7N8 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

7N8 closed yesterday higher at €0.15, an increase of 1.3423% from Thursday's close, completing a monthly decrease of -13.2184% or -€0.02. Over the past 12 months, 7N8 stock gained 18.8976%.
7N8 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XSTU (EUR).

7N8 Chart

People also search for

7ZT
Hamlet Biopharma AB (publ)
0.65
-0.9146%
J90
NurExone Biologic Inc.
0.29
-6.0703%
3HB
Aton S.A.
0
-54.5455%
Respiratorius AB (publ)
0.23
-4.1322%
Qlife Holding AB
0.16
+1.2658%

Integragen S.A. (7N8) FAQ

What is the stock price today?

The current price is €0.15.

On which exchange is it traded?

Integragen S.A. is listed on XSTU.

What is its stock symbol?

The ticker symbol is 7N8.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 3.07M.

Has Integragen S.A. ever had a stock split?

No, there has never been a stock split.

Integragen S.A. Profile

Biotechnology Industry
Healthcare Sector
Dr. Bernard Courtieu DVM, MBA CEO
XSTU Exchange
- ISIN
France Country
55 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

IntegraGen SA is a company specialized in providing comprehensive sequencing solutions, data management tools, and extensive support in biostatistics and bioinformatics primarily to researchers in France. The company's focus spans several genomic services including transcriptomics, epigenomics, DNA sequencing, and more, tailored towards cancer research, clinical research, agrigenomics, and microbial genomics. Established in 2000 with its headquarters in Évry, France, IntegraGen SA has expanded its reach and expertise over the years, now operating as a subsidiary of OncoDNA SA. The company is deeply committed to advancing research and clinical outcomes through state-of-the-art genomic services and innovative software solutions.

Products and Services

  • Genomic Services

    IntegraGen SA offers a wide array of genomic services such as transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. These services are designed to support researchers in uncovering genetic insights and advancing their scientific discoveries.

  • Clinical Research Services

    The company provides clinical grade sequencing and pharmacogenomics among other services, aimed at facilitating clinical research. This includes basic and human genetic research, supporting the development of personalized medicine and enhancing drug efficacy and safety.

  • Agrigenomic Services

    IntegraGen SA extends its expertise to the field of agrigenomics, offering services such as crop and livestock genotyping and high-throughput sequencing tailored for agriculture. These services help in enhancing crop production, livestock management, and overall agricultural productivity.

  • Microbial Genomics Services

    Comprehensive microbial genomics services are available, including whole-genome microbial sequencing and microbial transcriptomics. These services assist researchers in studying microbial communities, understanding their functions, and exploiting their capabilities for various applications.

  • MERCURY

    An online biological interpretation tool focused on oncology that assists pathologists and oncologists in converting raw data from high-throughput sequencing into comprehensive molecular reports. This tool is aimed at facilitating translational and clinical research in oncology.

  • SIRIUS

    A cloud-based software tool that enables the analysis of whole genome, whole exome, and gene panel sequencing data. SIRIUS is designed to streamline the genomic data analysis process, making it more accessible for researchers and clinicians.

  • Galileo

    This cloud-based application offers dynamic exploration of RNA-Seq expression data, providing researchers with advanced tools for the analysis and interpretation of gene expression patterns.

  • GeCo

    A genomic consulting service that grants researchers access to biostatistics and bioanalytics experts. GeCo is aimed at enhancing research outcomes by offering expert guidance in the analysis and interpretation of complex genomic data.

Contact Information

Address: Genopole Campus 1 BAt. 8
Phone: 33 1 60 91 09 00